For the Quarter Ending September 2025
APAC
• In China, the Pregabalin Price Index fell quarter-over-quarter in Q3 2025, driven by weak consumer demand.
• Pregabalin production costs were stable in Q3 2025, influenced by steady petrochemical feedstock costs.
• The demand outlook for Pregabalin faced moderation due to overall economic growth slowing in China during Q3 2025.
• China's Consumer Price Index declined 0.3% year-over-year in September 2025, signaling deflation and reduced purchasing power.
• Producer Price Index decreased 2.3% year-over-year in September 2025, reflecting lower input costs and weak industrial demand.
• The Manufacturing Index contracted in September 2025, indicating reduced industrial activity impacting the supply chain.
• Industrial production grew 6.5% year-over-year in September 2025, supporting a stable supply of chemical precursors.
• Global overcapacity in the chemicals sector, significantly influenced by China's expanding production, persisted in Q3 2025.
Why did the price of Pregabalin change in September 2025 in APAC?
• Weak consumer demand, with CPI declining 0.3% in September 2025, pressured Pregabalin prices.
• Producer Price Index fell 2.3% in September 2025, reflecting lower input costs and weak industrial demand.
• Contracting Manufacturing Index and 5.2% unemployment in September 2025 dampened overall market confidence.
Europe
• In Germany, the Pregabalin Price Index remained stable quarter-over-quarter in Q3 2025, balancing declining petrochemical costs with strong demand.
• Pregabalin production costs were influenced by a 1.7% decline in producer prices in September 2025, driven by lower energy costs.
• Elevated natural gas and electricity prices in Q3 2025 continued to challenge overall chemical manufacturing costs.
• Demand for Pregabalin saw a boost in Q3 2025, as German pharmaceutical sector output firmed.
• The Manufacturing Index contracted in Q3 2025, indicating broader industrial weakness, potentially impacting supply chains.
• Industrial production declined by 1.0% in September 2025, reflecting a weaker manufacturing environment for intermediates.
• Retail sales increased by 0.2% in September 2025, supporting stable consumer spending and healthcare system funding.
• The unemployment rate remained stable at 6.3% in September 2025, contributing to consistent consumer purchasing power.
• Pregabalin price forecast suggests continued stability, with strong pharmaceutical demand offsetting persistent high energy costs.
Why did the price of Pregabalin change in September 2025 in Europe?
• Producer prices fell 1.7% in September 2025, due to lower energy costs, reducing Pregabalin manufacturing expenses.
• Strong pharmaceutical demand in Q3 2025, with firming sector output, provided upward pressure on Pregabalin prices.
• Elevated natural gas and electricity prices in Q3 2025 continued to exert upward pressure on Pregabalin production costs.
North America
• In United States, the Pregabalin Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs and robust pharmaceutical demand.
• Pregabalin production costs increased due to a 2.6% rise in PPI in August 2025 and strengthened natural gas prices in September 2025.
• Pregabalin demand outlook was supported by robust US pharmaceutical demand in 2025 and a 5.42% rise in retail sales in September 2025.
• Wholesale chemical inventories eased in July 2025, suggesting a balanced supply-demand environment.
• US chemical imports rose in July 2025, narrowing the chemical trade surplus for the quarter.
• Overall industrial production saw a marginal 0.1% year-over-year increase in September 2025, indicating slower economic expansion.
• Declining consumer confidence and a 4.3% unemployment rate in September 2025 impacted healthcare spending.
• The 3.0% year-over-year CPI increase in September 2025 contributed to higher operational costs for manufacturers.
• US manufacturing output rose in August 2025, following a July decrease, indicating some industrial activity recovery.
Why did the price of Pregabalin change in September 2025 in North America?
• Production costs increased due to a 2.6% rise in PPI in August 2025 and strengthened natural gas prices.
• Robust US pharmaceutical demand in 2025 supported prices, despite declining consumer confidence in September 2025.
• Wholesale chemical inventories eased in July 2025, influencing supply dynamics and price stability.
